MannKind Operating Margin from 2010 to 2024
| MNKD Stock | USD 6.78 0.17 2.57% |
Check MannKind Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MannKind Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.2 M, Interest Expense of 26.4 M or Total Revenue of 208.9 M, as well as many indicators such as Price To Sales Ratio of 4.64, Dividend Yield of 0.0 or Days Sales Outstanding of 25.97. MannKind financial statements analysis is a perfect complement when working with MannKind Corp Valuation or Volatility modules.
MannKind | Operating Margin |
Latest MannKind Corp's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of MannKind Corp over the last few years. It is MannKind Corp's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MannKind Corp's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.22 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
MannKind Operating Margin Regression Statistics
| Arithmetic Mean | (479.09) | |
| Coefficient Of Variation | (262.34) | |
| Mean Deviation | 806.86 | |
| Median | (0.69) | |
| Standard Deviation | 1,257 | |
| Sample Variance | 1.6M | |
| Range | 4.2K | |
| R-Value | 0.50 | |
| Mean Square Error | 1.3M | |
| R-Squared | 0.25 | |
| Significance | 0.06 | |
| Slope | 139.26 | |
| Total Sum of Squares | 22.1M |
MannKind Operating Margin History
About MannKind Corp Financial Statements
MannKind Corp stakeholders use historical fundamental indicators, such as MannKind Corp's Operating Margin, to determine how well the company is positioned to perform in the future. Although MannKind Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in MannKind Corp's assets and liabilities are reflected in the revenues and expenses on MannKind Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in MannKind Corp. Please read more on our technical analysis and fundamental analysis pages.
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California. Mannkind Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 348 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MannKind Corp is a strong investment it is important to analyze MannKind Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MannKind Corp's future performance. For an informed investment choice regarding MannKind Stock, refer to the following important reports:Check out the analysis of MannKind Corp Correlation against competitors. For information on how to trade MannKind Stock refer to our How to Trade MannKind Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MannKind Corp. If investors know MannKind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MannKind Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.246 | Earnings Share 0.08 | Revenue Per Share 0.982 | Quarterly Revenue Growth 0.367 | Return On Assets 0.0912 |
The market value of MannKind Corp is measured differently than its book value, which is the value of MannKind that is recorded on the company's balance sheet. Investors also form their own opinion of MannKind Corp's value that differs from its market value or its book value, called intrinsic value, which is MannKind Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MannKind Corp's market value can be influenced by many factors that don't directly affect MannKind Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MannKind Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if MannKind Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MannKind Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.